AwardedPOLGoods
Sukcesywna dostawa leków w ramach programu lekowego - leczenie choroby Fabryego
- Published
- Published 8 December 2025
- Deadline
- Closed 13 January 2026
Overview
Przedmiotem zamówienia jest sukcesywna dostawa leku Agalsidasum Alpha, Agalsidasum Beta oraz Migalastatum w ramach programu lekowego - leczenie choroby Fabryego.
Key details
- Country
- POL
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Published
- 8 December 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- PLN 2,809,343
- Award date
- 2 March 2026
- Contract period
- — → 17 January 2027
- Komtur Polska Sp. z o.o.
- Sanofi Sp. z o.o.
- Takeda Pharma Sp. z o.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 March 2026
Contract Notice
8 December 2025
Contracting authority
Powiatowy Zespół Szpitali
Procuring entityOleśnica, POL
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.